Evidence map›Paper›PMID 33376937›Full record

ReviewJournal of pancreatic cancer2020

Update on the Role of Poly (ADP-Ribose) Polymerase Inhibitors in the DNA Repair-Deficient Pancreatic Cancers: A Narrative Review.

Anup Kasi, Mohammed Al-Jumayli, Robin Park, Joaquina Baranda, Weijing Sun

Open access · goldAbstract readReview
In one paragraph

Review in Journal of pancreatic cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. BRCA-mutant pancreatic ductal adenocarcinoma.British journal of cancer · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Anup KasiDivision of Medical Oncology, Department of Medicine, Kansas University Cancer Center, Kansas City, Kansas, USA.
Mohammed Al-JumayliDivision of Medical Oncology, Department of Medicine, Kansas University Cancer Center, Kansas City, Kansas, USA.
Robin ParkDepartment of Medicine, MetroWest Medical Center/Tufts University School of Medicine, Framingham, Massachusetts, USA.
Joaquina BarandaDivision of Medical Oncology, Department of Medicine, Kansas University Cancer Center, Kansas City, Kansas, USA.
Weijing SunDivision of Medical Oncology, Department of Medicine, Kansas University Cancer Center, Kansas City, Kansas, USA.
The University of Kansas Cancer Center · USMoffitt Cancer Center · USTufts University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

combination therapyDNA damage repairpancreatic adenocarcinomaPARP inhibitor

Identifiers

PMID33376937
PMCPMC7757687
OpenAlexW3113207457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.